Electrophysiological effects of risperidone in mammalian cardiac cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 366, Issue 4, 2002, Pages 350-356

  Magyar, János ^a,c   Bányász, Tamás ^a,c   Bagi, Zsolt ^b,c   Pacher, Pál ^b,c   Szentandrássy, Norbert ^a,c   Fülöp, László ^a,c   Kecskeméti, Valéria ^b,c   Nánási, Péter P ^a,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INOTEK CORPORATION   (United States)

Author keywords

Action potential duration; Antidepressant drugs; Cardiac myocytes; Potassium currents; Risperidone

Indexed keywords

ANTIARRHYTHMIC AGENT; NEUROLEPTIC AGENT; RISPERIDONE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; GUINEA PIG; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HEART REPOLARIZATION; KINETICS; LONG QT SYNDROME; MAMMAL; MICROELECTRODE; NONHUMAN; POTASSIUM CURRENT;

ACTION POTENTIALS; ANIMALS; CELLS, CULTURED; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; MALE; MYOCYTES, CARDIAC; PAPILLARY MUSCLES; RISPERIDONE;

EID: 0036381563     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0595-1     Document Type: Article

References (37)

1. Czekalla J, Beasley CM, Dellva MA, Berg PH, Grundy S (2001) Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. J Clin Psychiatry 62:191-198
2. Davis AS (1998) The pre-clinical assessment of QT interval prolongation: a comparison of in vitro and in vivo methods. Hum Exp Toxicol 17:677-680
3. Demolis JL, Funck-Brentano C, Ropers J, Ghadanfar M, Nichols DJ, Jaillon P (1996) Influence of dofetilide on QT interval duration and dispersion at various heart rates during exercise in humans. Circulation 94:1592-1599
4. Drici MD, Wang WX, Liu XK, Woosley Rl, Flockhart DA (1998) Prolongation of QT interval in isolated feline hearts by an-tipsychotic drugs. J Clin Psychopharmacol 18:477-481
5. Drolet B, Zhang S, Deschenes D, Rail J, Nadeau S, Zhou Z, Janu-ary CT, Turgeon J (1999a) Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 10:1597-1604
6. Drolet B, Vincent F, Rail J, Chahine M, Deschenes D, Nadeau S, Khalifa M, Hamelin BA, Turgeon J (1999b) Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. J Pharmacol Exp Ther 288:1261-1268
7. Ereshefsky L, Lacombe S (1993) Pharmacological profile of risperidone. Can J Psychiatry 38:S80-S88
8. Finkel SI (1997) Managing the behavioral and psychological signs and symptoms of dementia. Int Clin Psychopharmacol 12: S25-S28
9. Flugelman MY, Tal A, Pollack S, Hefez A, Weisstub EB, Gotsman MS, Lewis BS (1985) Psychotropic drugs and long QT syndromes: case reports. J Clin Psychiatry 46:290-291
10. Glassman AH, Bigger JT (2001) Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158:1774-1782
11. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100
12. Hohnloser SH, Singh BN (1995) Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors and clinical implications. J Cardiovasc Electrophysiol 6:920-936
13. Hondeghem LM, Snyders DJ (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation 81:686-890
14. Huang ML, Van Peer A, Woestenborghs R, De Coster R, Heykants J, Jansen AA, Zylicz Z, Visscher HW, Jonkman JH (1993) Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactine response in healthy subjects. Clin Pharmacol Ther 54:257-268
15. Kleiser E, Lehmann E, Kinzler E, Wurthmann C, Heinrich K (1995) Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia. J Clin Psychopharmacol 15:S45-S51
16. Kopala LC, Day C, Dillman B, Gardner D (1998) A case of risperidone overdose in early schizophrenia: a review of potential complications. J Psychiatry Neurosci 23:305-308
17. Laroussinie G, Zenut M, Beal M, Bernard C, Lavarenne J (1997) Intoxication aigue par la risperidone et perturbations ioniques et electrocardiographiques. Therapie 52:155-156
18. Lo Vecchio F, Hamilton RJ, Hoffman RJ (2000) Risperidone overdose. Am J Emerg Med 14:95-96
19. Magyar J, Bányász T, Szigligeti P, Körtvély Á, Jenákovits A, Nánási PP (2000) Electrophysiological effects of bimoclomol in canine ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 361:303-310
20. McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH (1998) A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry 55:633-641
21. Metzger E, Friedman R (1993) Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol 13:128-132
22. Pacher P, Unvári Z, Nánási PP, Kecskeméti V (1999) Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. Acta Physiol Scand 166:7-13
23. Pacher P, Magyar J, Szigligeti P, Bányász T, Pankucsi C, Korom S, Ungvári Z, Kecskeméti V, Nánási PP (2000) Electrophysiological effects of fluoxetine in mammalian cardiac tissues. Naunyn Schmiedebergs Arch Pharmacol 361:67-73
24. Rampe D, Murawsky MK, Grau J, Lewis EW (1998) The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. J Pharmacol Exp Ther 286:788-793
25. Ravin DS, Levenson JW (1997) Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother 31:867-870
26. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048-1052
27. Roden DM, Lazzara R, Rosen M, et al (1996) Multiple mechanisms in the long QT syndrome: current knowledge, gaps and future directions. Circulation 94:1996-2012
28. Scordo MG, Spina E, Facciola G, Avenoso A, Johansson I, Dahl ML (1999) Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone. Psychopharmacology (Berl) 147:300-305
29. Suessbrich H, Schönherr R, Heinemann SH, Attali B, Lang F, Busch AE (1997) The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 120:968-974
30. Thomas D, Gut B, Wendt-Nordahl G, Kiehn J (2002) The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. J Pharmacol Exp Ther (in press)
31. + current activation in guinea-pig ventricular myocytes. Circ Res 74:687-699
32. Ks in dog ventricular muscle and Purkinje fibre repolarization. J Physiol (Lond) 523:67-81
33. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival with oral d-sotalol. Lancet 348:7-12
34. Warner JP, Barnes TR, Henry JA (1996) Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr Scand 93:311-313
35. + current in pituitary GH3 cells. Neuropsychopharmacology 23:676-689
36. Yerrabolu M, Prabhudesai S, Tawam M, Winter L, Kamalesh M (2000) Effect of risperidone on QT interval and QT dispersion in the elderly. Heart Disease 2:10-12
37. Zarate CA, Baldessarini RJ, Siegel AJ, Nakamura A, McDonald J, Muir-Hutchinson LA, Cherkerzian T, Tohen M (1997) Risperidone in elderly: a pharmacoepidemiologic study. J Clin Psychiatry 58:311-317